Literature DB >> 11914043

IPF-1 gene variation and the development of type 2 diabetes.

Kristi Silver1, Archana Shetty.   

Abstract

Insulin promotor factor-1 (IPF-1) is a gene critical for pancreatic development and insulin transcription. We genotyped U.S. Caucasians with (n = 217) and without (n = 176) Type 2 diabetes to determine if three previously identified variants (Cys18Arg, Asp76Asn, Arg197His) in the IPF-1 gene play a role in the development of Type 2 diabetes. The Cys18Arg and Arg197His variants were not present in any subjects. The Asp76Asn variant was found in one control subject (0.9%) and none of the diabetic subjects. Similarly, none of the variants were detected in African American subjects with (n = 78) and without (n = 82) Type 2 diabetes. In conclusion, these variants are rare or absent in U.S. Caucasians and African Americans and therefore, unlikely to play a significant role in the development of Type 2 diabetes in these populations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11914043     DOI: 10.1006/mgme.2001.3291

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  3 in total

1.  Role of the D76N polymorphism of insulin promoter factor-1 in predisposing to Type 2 diabetes.

Authors:  K R Owen; J C Evans; T M Frayling; A T Hattersley; M I McCarthy; M Walker; G A Hitman
Journal:  Diabetologia       Date:  2004-05-07       Impact factor: 10.122

2.  Evaluation of a SNP map of 6q24-27 confirms diabetic nephropathy loci and identifies novel associations in type 2 diabetes patients with nephropathy from an African-American population.

Authors:  Tennille S Leak; Josyf C Mychaleckyj; Shelly G Smith; Keith L Keene; Candace J Gordon; Pamela J Hicks; Barry I Freedman; Donald W Bowden; Michèle M Sale
Journal:  Hum Genet       Date:  2008-06-17       Impact factor: 4.132

Review 3.  Insights on pathogenesis of type 2 diabetes from MODY genetics.

Authors:  Michael N Weedon; Timothy M Frayling
Journal:  Curr Diab Rep       Date:  2007-04       Impact factor: 5.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.